| S9851 |
Danuglipron (PF-06882961) |
Danuglipron (PF-06882961), a non-peptide agonist, activates the canonical G protein signaling activity only in the Glucagon-like peptide-1 (GLP-1) receptor with Trp33ECD. |
Selective |
|
| S8256 |
Liraglutide |
Liraglutide is a long-acting glucagon-like peptide-1(GLP-1) receptor agonist. |
Selective |
|
| S8517 |
Lixisenatide |
Lixisenatide (Lyxumia, Adlyxin, ZP10A peptide, AVE0010) is a once-daily short-acting glucagon-like peptide-1 (GLP-1) receptor agonist (GLP-1RA) with an IC50 of 1.4 nM for the human GLP-1 receptor in receptor binding studies. |
Selective |
GLP-1R, IC50: 1.4 nM |
| S9697 |
Semaglutide Sodium |
Semaglutide Sodium (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217), a long-acting glucagon-like peptide 1 (GLP-1) analogue, is a GLP-1 receptor agonist with the potential for the treatment of type 2 diabetes mellitus (T2DM). |
Selective |
|
